Expansion of myeloid-derived suppressor cells in the peripheral blood of patients with ankylosing spondylitis
Expansion of myeloid-derived suppressor cells (MDSCs) due to impaired differentiation of myeloid progenitor cells under conditions of inflammation was described in a number of autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus, and type 1 diabetes mellitus. Studying th...
Main Authors: | A. Yu. Morenkova, M. A. Tikhonova, T. V. Tyrinova, E. V. Batorov, A. E. Sizikov, O. A. Chumasova, A. E. Sulutian, A. A. Ostanin, E. R. Chernykh |
---|---|
Format: | Article |
Language: | Russian |
Published: |
St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
2021-05-01
|
Series: | Медицинская иммунология |
Subjects: | |
Online Access: | https://www.mimmun.ru/mimmun/article/view/2143 |
Similar Items
-
Expansion and activation of monocytic-myeloid-derived suppressor cell via STAT3/arginase-I signaling in patients with ankylosing spondylitis
by: Yu-feng Liu, et al.
Published: (2018-08-01) -
Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy
by: Zhaonian Hao, et al.
Published: (2021-10-01) -
Murine gammaherpesvirus-68 expands, but does not activate, CD11b<sup>+</sup> gr-1<sup>+</sup> splenocytes in vivo
by: Nelson Daniel A, et al.
Published: (2012-04-01) -
Discovery of Myeloid-Derived Suppressor Cell-Specific Metabolism by Metabolomic and Lipidomic Profiling
by: Jisu Kim, et al.
Published: (2023-03-01) -
Myeloid-derived suppressor cells as biomarkers of the effectiveness of therapy with new biological agents in axial spondyloarthritis
by: T. V. Tyrinova, et al.
Published: (2023-06-01)